OTCMKTS:ACHFF

Arch Biopartners Stock Earnings Reports

etoro logo Buy ACHFF
*Your capital is at risk
$0.598
+0.0309 (+5.44%)
At Close: Jul 10, 2026

Arch Biopartners Earnings Calls

Jun 30, 2026 (Upcoming)
Release date Aug 27, 2026
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -
Expected change +/- 4.80%
Mar 31, 2026
Release date Jun 01, 2026
EPS estimate -
EPS actual -$0.0100
Revenue estimate -
Revenue actual -
Dec 31, 2025
-$0.0200 (-39.28%)
Release date Mar 02, 2026
EPS estimate -$0.0144
EPS actual -$0.0200
EPS Surprise -39.28%
Revenue estimate -
Revenue actual -
Sep 30, 2025
-$0.0029 (79.53%)
Release date Jan 28, 2026
EPS estimate -$0.0144
EPS actual -$0.0029
EPS Surprise 79.53%
Revenue estimate -
Revenue actual -

Last 4 Quarters for Arch Biopartners

Below you can see how ACHFF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Sep 30, 2025 Beat
Release date Jan 28, 2026
Price on release $0.744
EPS estimate -$0.0144
EPS actual -$0.0029
EPS surprise 79.53%
Date Price
Jan 22, 2026 $0.91
Jan 23, 2026 $0.91
Jan 26, 2026 $0.88
Jan 27, 2026 $0.85
Jan 28, 2026 $0.744
Jan 29, 2026 $0.710
Jan 30, 2026 $0.765
Feb 02, 2026 $0.745
Feb 03, 2026 $0.796
4 days before -18.52%
4 days after 6.98%
On release day -4.57%
Change in period -12.83%
Dec 31, 2025 Missed
Release date Mar 02, 2026
Price on release $0.600
EPS estimate -$0.0144
EPS actual -$0.0200
EPS surprise -39.28%
Date Price
Feb 24, 2026 $0.612
Feb 25, 2026 $0.612
Feb 26, 2026 $0.610
Feb 27, 2026 $0.582
Mar 02, 2026 $0.600
Mar 03, 2026 $0.575
Mar 04, 2026 $0.580
Mar 05, 2026 $0.578
Mar 06, 2026 $0.577
4 days before -1.96%
4 days after -3.92%
On release day -4.17%
Change in period -5.80%
Mar 31, 2026
Release date Jun 01, 2026
Price on release $0.370
EPS estimate -
EPS actual -$0.0100
Date Price
May 26, 2026 $0.316
May 27, 2026 $0.316
May 28, 2026 $0.322
May 29, 2026 $0.317
Jun 01, 2026 $0.370
Jun 02, 2026 $0.350
Jun 03, 2026 $0.338
Jun 04, 2026 $0.362
Jun 05, 2026 $0.362
4 days before 17.05%
4 days after -2.24%
On release day -5.30%
Change in period 14.43%
Jun 30, 2026 (Upcoming)
Release date Aug 27, 2026
Price on release -
EPS estimate -
EPS actual -
Date Price
Jul 06, 2026 $0.551
Jul 07, 2026 $0.556
Jul 08, 2026 $0.560
Jul 09, 2026 $0.568
Jul 10, 2026 $0.598

Arch Biopartners Earnings History

Earnings Calendar

FAQ

When is the earnings report for ACHFF?
Arch Biopartners Inc (ACHFF) has scheduled its earnings report for Aug 27, 2026 after the markets close.

What is the ACHFF price-to-earnings (P/E) ratio?
ACHFF P/E ratio as of Jul 10, 2026 (TTM) is -21.94.

What is the ACHFF EPS forecast?
The forecasted EPS (Earnings Per Share) for Arch Biopartners Inc (ACHFF) for the first fiscal quarter 2026 is $.

What are Arch Biopartners Inc's retained earnings?
On its balance sheet, Arch Biopartners Inc reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ARCH BIOPARTNERS INC
Arch Biopartners
Arch Biopartners Inc., a biotechnology company, develops technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat or prevent dipeptidase-1 mediated organ inflammation in the lungs, liver, or kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, a drug candidate for treating or preventing antibiotic resistant bacteri...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE